Search for a platelet-activating factor receptor in the Trypanosoma cruzi proteome: a potential target for Chagas disease chemotherapy

Chagas disease (CD) causes the highest burden of parasitic diseases in the Western Hemisphere and is therefore a priority for drug research and development. Platelet-activating factor (PAF) causes the CD parasite Trypanosoma cruzi to differentiate, which suggests that the parasite may express PAF receptors. Here, we explored the T. cruzi proteome for PAF receptor-like proteins. From a total of 23,000 protein sequences, we identified 29 hypothetical proteins that are predicted to have seven transmembrane domains (TMDs), which is the main characteristic of the G protein-coupled receptors (GPCRs), including the PAF receptor. The TMDs of these sequences were independently aligned with domains from 25 animal PAF receptors and the sequences were analysed for conserved residues. The conservation score mean values for the TMDs of the hypothetical proteins ranged from 31.7-44.1%, which suggests that if the putative T. cruzi PAF receptor is among the sequences identified, the TMDs are not highly conserved. These results suggest that T. cruzi contains several GPCR-like proteins and that one of these GPCRs may be a PAF receptor. Future studies may further validate the PAF receptor as a target for CD chemotherapy.

Saved in:
Bibliographic Details
Main Authors: Kawano,Daniel Fábio, Silva,Vinicius Barreto da, Jorge,Daniel Macedo de Melo, Silva,Carlos Henrique Tomich de Paula da, Carvalho,Ivone
Format: Digital revista
Language:English
Published: Instituto Oswaldo Cruz, Ministério da Saúde 2011
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762011000800010
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0074-02762011000800010
record_format ojs
spelling oai:scielo:S0074-027620110008000102013-04-08Search for a platelet-activating factor receptor in the Trypanosoma cruzi proteome: a potential target for Chagas disease chemotherapyKawano,Daniel FábioSilva,Vinicius Barreto daJorge,Daniel Macedo de MeloSilva,Carlos Henrique Tomich de Paula daCarvalho,Ivone PAF GPCR Trypanosoma cruzi Chagas disease bioinformatics proteome Chagas disease (CD) causes the highest burden of parasitic diseases in the Western Hemisphere and is therefore a priority for drug research and development. Platelet-activating factor (PAF) causes the CD parasite Trypanosoma cruzi to differentiate, which suggests that the parasite may express PAF receptors. Here, we explored the T. cruzi proteome for PAF receptor-like proteins. From a total of 23,000 protein sequences, we identified 29 hypothetical proteins that are predicted to have seven transmembrane domains (TMDs), which is the main characteristic of the G protein-coupled receptors (GPCRs), including the PAF receptor. The TMDs of these sequences were independently aligned with domains from 25 animal PAF receptors and the sequences were analysed for conserved residues. The conservation score mean values for the TMDs of the hypothetical proteins ranged from 31.7-44.1%, which suggests that if the putative T. cruzi PAF receptor is among the sequences identified, the TMDs are not highly conserved. These results suggest that T. cruzi contains several GPCR-like proteins and that one of these GPCRs may be a PAF receptor. Future studies may further validate the PAF receptor as a target for CD chemotherapy.info:eu-repo/semantics/openAccessInstituto Oswaldo Cruz, Ministério da SaúdeMemórias do Instituto Oswaldo Cruz v.106 n.8 20112011-12-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762011000800010en10.1590/S0074-02762011000800010
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Kawano,Daniel Fábio
Silva,Vinicius Barreto da
Jorge,Daniel Macedo de Melo
Silva,Carlos Henrique Tomich de Paula da
Carvalho,Ivone
spellingShingle Kawano,Daniel Fábio
Silva,Vinicius Barreto da
Jorge,Daniel Macedo de Melo
Silva,Carlos Henrique Tomich de Paula da
Carvalho,Ivone
Search for a platelet-activating factor receptor in the Trypanosoma cruzi proteome: a potential target for Chagas disease chemotherapy
author_facet Kawano,Daniel Fábio
Silva,Vinicius Barreto da
Jorge,Daniel Macedo de Melo
Silva,Carlos Henrique Tomich de Paula da
Carvalho,Ivone
author_sort Kawano,Daniel Fábio
title Search for a platelet-activating factor receptor in the Trypanosoma cruzi proteome: a potential target for Chagas disease chemotherapy
title_short Search for a platelet-activating factor receptor in the Trypanosoma cruzi proteome: a potential target for Chagas disease chemotherapy
title_full Search for a platelet-activating factor receptor in the Trypanosoma cruzi proteome: a potential target for Chagas disease chemotherapy
title_fullStr Search for a platelet-activating factor receptor in the Trypanosoma cruzi proteome: a potential target for Chagas disease chemotherapy
title_full_unstemmed Search for a platelet-activating factor receptor in the Trypanosoma cruzi proteome: a potential target for Chagas disease chemotherapy
title_sort search for a platelet-activating factor receptor in the trypanosoma cruzi proteome: a potential target for chagas disease chemotherapy
description Chagas disease (CD) causes the highest burden of parasitic diseases in the Western Hemisphere and is therefore a priority for drug research and development. Platelet-activating factor (PAF) causes the CD parasite Trypanosoma cruzi to differentiate, which suggests that the parasite may express PAF receptors. Here, we explored the T. cruzi proteome for PAF receptor-like proteins. From a total of 23,000 protein sequences, we identified 29 hypothetical proteins that are predicted to have seven transmembrane domains (TMDs), which is the main characteristic of the G protein-coupled receptors (GPCRs), including the PAF receptor. The TMDs of these sequences were independently aligned with domains from 25 animal PAF receptors and the sequences were analysed for conserved residues. The conservation score mean values for the TMDs of the hypothetical proteins ranged from 31.7-44.1%, which suggests that if the putative T. cruzi PAF receptor is among the sequences identified, the TMDs are not highly conserved. These results suggest that T. cruzi contains several GPCR-like proteins and that one of these GPCRs may be a PAF receptor. Future studies may further validate the PAF receptor as a target for CD chemotherapy.
publisher Instituto Oswaldo Cruz, Ministério da Saúde
publishDate 2011
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762011000800010
work_keys_str_mv AT kawanodanielfabio searchforaplateletactivatingfactorreceptorinthetrypanosomacruziproteomeapotentialtargetforchagasdiseasechemotherapy
AT silvaviniciusbarretoda searchforaplateletactivatingfactorreceptorinthetrypanosomacruziproteomeapotentialtargetforchagasdiseasechemotherapy
AT jorgedanielmacedodemelo searchforaplateletactivatingfactorreceptorinthetrypanosomacruziproteomeapotentialtargetforchagasdiseasechemotherapy
AT silvacarloshenriquetomichdepaulada searchforaplateletactivatingfactorreceptorinthetrypanosomacruziproteomeapotentialtargetforchagasdiseasechemotherapy
AT carvalhoivone searchforaplateletactivatingfactorreceptorinthetrypanosomacruziproteomeapotentialtargetforchagasdiseasechemotherapy
_version_ 1756383704305893376